… of Paxlovid on death and hospitalization for COVID-19 patients. Seven studies described
the death of COVID-19 patients in the Paxlovid … the hospitalization of COVID-19 patients. Our …

… Paxlovid) are effective in reducing the mortality and hospitalization rates in patients with
COVID-19… of adverse events, thus exhibiting good overall safety. These three oral antiviral drugs …

… groups in terms of COVID-19 rebound (OR … safety of Paxlovid in the treatment of patients
with COVID-19. Further research is needed to investigate the COVID-19 rebound after Paxlovid …

… and safety outcomes for coronavirus disease 2019 (COVID-19) patients treated with Paxlovid.
… In conclusion, Paxlovid effectively reduced the risks of death, hospitalisation, death or …

… adults with COVID-19. We aimed at studying the efficacy and safety of Paxlovid in hospitalized
… articles that describe the Paxlovid treatment in patients with COVID-19 infection, using the …

… Therefore, this study investigated the drug safety of Paxlovid. … safety and effectively of
Paxlovid therapy in reducing the time of hospital stay for patients with mild to moderate COVID-19 …

… The evidence for the safety of Paxovid in routine clinical use, however, is still limited, and
the concerns of viral rebound and recurrence of COVID-19 symptoms following Paxlovid …

… safety pharmacology and nonclinical toxicity profiles of nirmatrelvir support clinical development
and use of Paxlovid for treatment of COVID-19… of nonclinical safety pharmacology and …

… need to investigate the safety and efficacy of Paxlovid in elderly … the safety, tolerability,
and therapeutic effects of Paxlovid … with mild or moderate COVID-19 caused by the omicron …

… To generate a primary analysis of the safety and efficacy of Paxlovid in treating COVID-19-infected
children, 30 age-matched controls were selected. The underlying diseases in the …